Literature DB >> 9083328

Interleukin 2 exerts autocrine stimulation on murine T-cell leukaemia growth.

C I Waldner1, C Mongini, E Alvarez, M Sánchez Lockhart, M J Gravisaco, S E Hajos.   

Abstract

As it has been suggested that an autocrine mechanism may control tumour cell growth, in this work cells from a spontaneous murine T lymphocyte leukaemia (LB) expressing the interleukin-2 receptor (IL-2R) (CD25) were evaluated in vitro for IL-2-mediated autocrine growth. Cells grew readily in culture and proliferation was enhanced by the addition of recombinant IL-2 but inhibited by monoclonal antibodies against either IL-2 or IL-2 receptor, in the absence of exogenous IL-2. Cyclosporin A also inhibited LB cell growth. However, when exogenous IL-2 was added together with cyclosporin A, cell proliferation proved similar to controls. Using reverse transcription polymerase chain reaction (PCR), mRNA for IL-2 was found to be present in tumour cells. Our findings support the hypothesis that LB tumour cell proliferation is mediated by an autocrine pathway involving endogenous IL-2 generation, despite the fact that these cells are not dependent on exogenous IL-2 to grow in culture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083328      PMCID: PMC2222760          DOI: 10.1038/bjc.1997.165

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

Review 2.  The IL-2 receptor complex: its structure, function, and target genes.

Authors:  Y Minami; T Kono; T Miyazaki; T Taniguchi
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 3.  Autocrine growth factors and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

4.  The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro.

Authors:  T R Malek; G Ortega; J P Jakway; C Chan; E M Shevach
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells.

Authors:  S K Arya; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

7.  Autocrine growth of a human T-cell line is inhibited by cyclosporin A.

Authors:  A Dautry-Varsat; A Hémar; V Cornet; V Duprez
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

Review 8.  Interleukin-2: inception, impact, and implications.

Authors:  K A Smith
Journal:  Science       Date:  1988-05-27       Impact factor: 47.728

9.  Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody.

Authors:  M Tsudo; T Uchiyama; H Uchino; J Yodoi
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

10.  Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2.

Authors:  V Duprez; G Lenoir; A Dautry-Varsat
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.